# Study Evaluating the Safety and Efficacy of JWCAR029 in Adult Subjects With Relapsed and Refractory B-cell Non-Hodgkin Lymphoma

> **NCT03355859** · PHASE1 · UNKNOWN · sponsor: **Zhao Weili** · enrollment: 10 (estimated)

## Conditions studied

- Non Hodgkin Lymphoma

## Interventions

- **BIOLOGICAL:** JWCAR029

## Key facts

- **NCT ID:** NCT03355859
- **Lead sponsor:** Zhao Weili
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-01-05
- **Primary completion:** 2019-12
- **Final completion:** 2022-03
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2019-07-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03355859

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03355859, "Study Evaluating the Safety and Efficacy of JWCAR029 in Adult Subjects With Relapsed and Refractory B-cell Non-Hodgkin Lymphoma". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT03355859. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*